πŸŽ‰ Omnihelp & Fitt customers β€” your Triba programme access unlocks from July 2026.
Triba Health

Clinically validated metabolic care

Reversing TypeΒ 2 diabetes and metabolic disease progression by empowering self-care

A dietician and patient reviewing a food-first metabolic care plan together.

Triba Health delivers evidence-based digital programmes that help insurers manage β€” and in many cases reverse β€” Type 2 diabetes and other metabolic diseases. Our programmes empower patients to take control of their health again through simple, sustainable self-care.

Lives touched
0+
Markets live
0 countries
Trustpilot
0.0

In partnership with

Omnihelp
Strove
Celto
Faglige Seniorer
Redminkrop

The science

One common root cause. Many chronic diseases.

Most metabolic diseases β€” diabetes, heart disease, obesity, fatty liver β€” share a single upstream driver: insulin resistance, caused by modern lifestyle. Address the root, and the entire cascade improves.

Insulin resistance tree β€” diseases branching from the same metabolic root cause: heart disease, obesity, type 2 diabetes, fatty liver, Alzheimer's, certain cancers, gout, PCOS, hypertension and inflammation, rooted in sugar, seed oils and chronic stress.
Adapted from Chong KS et al. 2024 Β· see references
  1. 01 Β· The root cause

    Lifestyle factors

    Ultra-processed foods, excess sugar, sedentary habits, poor sleep and chronic stress drive insulin levels too high β€” a condition called hyperinsulinaemia. These are everyday choices that can be changed.

    The good news: lifestyle is modifiable.

  2. 02 Β· What happens inside

    Insulin resistance develops

    Over time, your cells stop responding to insulin properly. Blood sugar rises, belly fat accumulates, blood pressure climbs, and cholesterol worsens β€” often silently, long before a diagnosis.

    Tracked by HbA1c β€” your average blood sugar over 3 months.

  3. 03 Β· The consequences

    A cascade of chronic diseases

    The same metabolic root feeds Type 2 diabetes, heart disease, fatty liver, obesity, hypertension, and more. These aren't separate problems β€” they share one origin.

    Addressing the root early dramatically reduces long-term risk.

Clinical evidence

Results from Africa and Europe.

Two independent studies measuring the effect of Triba's intervention on HbA1c, body weight, and patient satisfaction.

South Africa β€” Key results

Medshield
HSRC

HbA1c reduction

βˆ’0.0%

Clinically meaningful improvement in blood glucose control.

Meaningful reduction

0%

Share of participants achieving meaningful HbA1c reduction.

Net Promoter Score

0

Exceptional patient satisfaction and loyalty.

Research partner
Medshield & HSRC
Duration
6 months
Primary endpoint
Change in average blood glucose (HbA1c)
Design
Proof of Concept study

Denmark β€” Key results

HbA1c reduction

βˆ’0.0mmol/mol

Materially lower risk of micro- and macrovascular complications.

Weight reduction

βˆ’0.0%

Body weight reduction at 6 months.

Non-HDL
change

βˆ’0.00mmol/L

Lipid profile improvement at 6 months.

Net Promoter Score

>0

Best-in-class patient satisfaction.

Research partner
Internal
Duration
6 months
Primary endpoint
Change in average blood glucose (HbA1c)
Design
Internal data set

Study data available on request.

For patients β€” why self-care matters

The patient is the primary caregiver.

95%by the patient
β€œMore than 95% of diabetes care is done by the patient.”
β€” Funnell MM, Anderson RM. JAMA. 2000.
95% β€” Patient self-care
5% β€” Clinical visits

Between doctor visits, it's you β€” every day β€” who manages what you eat, how you move, how you sleep, and how you handle stress. Traditional treatment often leads to slow, continuous disease progression. There is a better way.

At Triba, we empower you to take control again. We don't hand out strict meal plans or endless checklists. Instead, we teach you the knowledge, explain the β€œwhy” behind every change, and guide you toward sustainable, enjoyable habits that fit real life.

This is how real, lasting reversal happens β€” through understanding and self-care that lasts.

The programme

What members actually experience.

A 6–12 month programme with 4 main modules: core diabetes & nutrition intervention (the key focus), followed by sleep, stress, and light movement at your own interest and pace. Clients engage with dieticians, doctors and guest experts through weekly sessions and inspirational talks. Our team is available throughout the week for questions, learning, sharing, and fun group sessions.

Onboarding flow β€” mobile app screen

Step 01

Onboarding

Members complete a structured metabolic assessment, share baseline labs, and meet their coach in one of many available group sessions in the first week.

  • Personalised metabolic baseline
  • Getting familiar with the programme
  • Start engaging with your coaches and other members
Daily programme β€” mobile app screen

Step 02

Daily programme

Evidence-based content, food-first meal guidance, daily habit tracking and an in-app peer community built around metabolic remission.

  • Micro-lessons, 5–10 min/day
  • Food-first meal guidance
  • Group sessions & Expert talks
Clinician-patient coaching interaction

Step 03

Clinical touchpoints

Doctor drop-ins for urgent advice, health coaches available via chat throughout the week, and 1:1 coaching sessions for Plus members.

  • Clinician-reviewed progress
  • Doctor drop-ins for urgent advice
  • Health coaches available per chat and 1:1 for Plus members

In their words

Members on what remission actually feels like.

Nadine

β€œTRIBA has been life-changing. I joined 2 months ago with fasting blood sugar at 12 and weighing 114 kg. Now my fasting sugar is under 7 and I'm at 98.8 kg. What sets TRIBA apart is the incredible family and coaching support β€” knowing I'm not alone has been the greatest source of encouragement. The impact goes beyond just me β€” with better blood sugar and improved health, my mood has drastically improved, and my family can feel the positive difference. TRIBA isn't just a program; it's a life-changing community.”

NadineSouth Africa
01
09

For insurers

Built for health & life insurers who want to reshape their risk book.

Key benefits for insurers

Clinical outcomes that move the actuarial needle.

Four measurable effects observed across both cohorts β€” each mapped to a direct insurer impact.

  • >0.8%

    HbA1c

    Reduction in glycated haemoglobin β€” 6 months data across 2 studies.

    Lower risk of micro- and macrovascular complications downstream.

  • >5%

    Body weight loss

    Clinically meaningful body weight loss β€” 6 months data across 2 studies.

    Weight loss correlates with reduced BMI-driven claim categories.

  • >80

    NPS

    Net Promoter Score consistently above 80 β€” a best-in-class engagement signal.

    High retention and word-of-mouth acquisition within member populations.

  • MAU

    Risk-shared billing

    We only charge for monthly active users β€” direct engagement alignment.

    Spend tracks outcomes, not entitlements.

Request references β†’

Use cases

Why this matters for insurers.

Type 2 diabetes compounds risk across every major cover line. Addressing it upstream shifts the economics.

Life Insurance Cover

+0% / +0%

CV & MI mortality increase

Type 2 Diabetes increases mortality risk significantly β€” leading to lower insurance durations, increased premiums, or declined cover.

Impact: Shorter pay-in periods, earlier payouts, loaded contracts.

Ballotari P et al. Int J Endocrinol. 2015;2015:914057.

Health / Medical Aid

+0%

Per member cost vs non-diabetic

Diabetic members cost on average more than 3Γ— as much as non-diabetic members β€” a significant driver of overall scheme expenditure.

Impact: Unsustainable cost pressure on medical aid schemes.

Source: South African medical aid data.

Income Disability Cover

>0%

Returned to work

Swiss Re case: 14 claimants referred (86% acceptance); nutrition-first programme. Outcomes: avg 7.2 kg weight loss, waist ↓ up to 10 cm, reduced medications.

Impact: Claimants return to work, reserves released at minimal cost.

Swiss Re. UK Disability Insurance Pilot. swissre.com

Severe Illness Cover

0%

Of RSA claims driven by the Big Four

T2DM drives cancer, heart attack, stroke, and CABG β€” the highest cost category for life insurers. Metabolic intervention reduces the upstream risk.

Impact: Lower severe illness payouts through upstream risk reduction.

Source: Old Mutual Protect & Discovery Life claims statistics.

Pipeline

Programs in development.

Where each clinical programme sits today, from initial data through to live deployment.

Completed
In progress
ProgramDataPilotLive

T2D remission programme

Denmark

T2D remission programme

South Africa

Gestational diabetes

Denmark

Sleep apnea / obesity / diabetes

Denmark

Research partners

Medshield
Region Nordjylland
Sygehus Lillebælt
HSRC

Partnership opportunities

Built with insurers, not sold to them.

Triba already delivers clinical remission programmes in Denmark and South Africa. We are ready to co-create the next market with a health or life insurer willing to build the evidence together.

Every market is unique. We co-create the first local evidence with you β€” a paid, win-win rollout that simultaneously builds market-specific data for claim savings and risk improvement.

Looking to reduce claim cost, improve risk profiles and strengthen member loyalty β€” with data that is 100% relevant to your portfolio?

  1. 01

    Co-create

    We design the local programme jointly with your clinical and actuarial teams β€” evidence first, branding second.

  2. 02

    Launch in under 3 months

    Signed agreement to first member enrolled: under 90 days, including localisation, your brand and operational setup.

  3. 03

    Share the risk

    We only charge for monthly active users. Spend tracks engagement β€” and engagement drives outcomes.

Start the conversation

Ready to see the data on your portfolio?

We respond to every insurer enquiry within two business days. Request a clinical brief, book a demo or an introductory meeting β€” we'll match you with the right person.

Contact form

References

  1. 1Chong KS etΒ al. Longitudinal economic burden of incident complications among metabolic syndrome populations. Cardiovascular Diabetology 2024;23:246.
  2. 2Triba Health internal study data (Denmark cohort, nΒ =Β 64, 2022–2024). Full protocol available on request.
  3. 3Stratton IM etΒ al. Association of glycaemia with macrovascular and microvascular complications of typeΒ 2 diabetes (UKPDS 35): prospective observational study. BMJ2000;321:405–12.
  4. 4Funnell MM, Anderson RM. The Problem With Compliance in Diabetes. JAMA. 2000;284(13):1709. doi:10.1001/jama.284.13.1709-JMS1004-6-1
  5. 5Ballotari P etΒ al. Sex Differences in Cardiovascular Mortality in Diabetics and Nondiabetic Subjects: A Population-Based Study (Italy). Int J Endocrinol. 2015;2015:914057. doi:10.1155/2015/914057
  6. 6Swiss Re. Leading Metabolic Health: UK Disability Insurance Pilot. swissre.com. Available at: swissre.com